GlassScriptPhysician profile
Andrew N Odland
NPI 1265794390
$6,675.07
in general payments reported to CMS, 2019-2025
14 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.21 · 2020: $2,970 · 2021: $1,180 · 2022: $1,403 · 2023: $904 · 2024: $16.62 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $822 · Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $821.70 |
| Food and Beverage | $216.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,266.57 | 2021-2023 | Comprehensive Shoulder System, Rosa |
| Wardlow Enterprises | $2,015.34 | 2020-2021 | |
| Arthrex, INC. | $1,839.44 | 2020-2021 | |
| Orthalign INC | $118.58 | 2022 | |
| Smith+Nephew, INC. | $108.72 | 2019-2022 | |
| Stryker Corporation | $98.82 | 2020-2023 | Aequalis Ascend Flex |
| Pacira Pharmaceuticals Incorporated | $48.86 | 2023-2025 | Zilretta, Exparel, Iovera |
| Depuy Synthes Sales INC. | $37.67 | 2025 | Monovisc |
| Prism Medical | $33.28 | 2025 | |
| Maxx Orthopedics, INC. | $28.31 | 2019 | |
| Pacira Therapeutics, INC. | $26.16 | 2019-2020 | |
| Ethicon US, LLC | $21.14 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $16.92 | 2025 | |
| Inspire Medical Systems, INC. | $15.26 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Odland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.